These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25407871)

  • 1. US Food and Drug Administration medical device review and approval; myths, misconceptions, realities, and potential policy changes.
    Wallner PE; Sandler HM
    Pract Radiat Oncol; 2014; 4(6):472-8. PubMed ID: 25407871
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical device recalls: get it right the first time: Comment on "Medical device recalls and the FDA approval process".
    Redberg RF; Dhruva SS
    Arch Intern Med; 2011 Jun; 171(11):1011-2. PubMed ID: 21321286
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA, off-label use, and informed consent: debunking myths and misconceptions.
    Beck JM; Azari ED
    Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
    [No Abstract]   [Full Text] [Related]  

  • 4. Roche's microarray tests US FDA's diagnostic policy.
    Kling J
    Nat Biotechnol; 2003 Sep; 21(9):959-60. PubMed ID: 12949543
    [No Abstract]   [Full Text] [Related]  

  • 5. Benefit-Risk Assessments at the US Food and Drug Administration: Finding the Balance.
    Califf RM
    JAMA; 2017 Feb; 317(7):693-694. PubMed ID: 28114599
    [No Abstract]   [Full Text] [Related]  

  • 6. US Congress considers new tracking system for medical devices after excessive recalls.
    Epstein K
    BMJ; 2012 Apr; 344():e2915. PubMed ID: 22529316
    [No Abstract]   [Full Text] [Related]  

  • 7. In the hot seat. Study questions FDA's fast-track process.
    McKinney M
    Mod Healthc; 2011 Feb; 41(8):16. PubMed ID: 21608192
    [No Abstract]   [Full Text] [Related]  

  • 8. A US FDA medical device update, Part II.
    Donawa ME
    Med Device Technol; 1996 Sep; 7(7):12-6, 18. PubMed ID: 10163518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vioxx, radiology, and the Food and Drug Administration.
    Pentecost MJ
    J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA recalls not as alarming as they seem.
    Connor JT; Lewis RJ; Berry DA; Berry SM
    Arch Intern Med; 2011 Jun; 171(11):1044-5; author reply 1045-6. PubMed ID: 21670380
    [No Abstract]   [Full Text] [Related]  

  • 11. Advisory committees" critical to the FDA's product review process.
    Rados C
    FDA Consum; 2004; 38(1):17-9. PubMed ID: 15032199
    [No Abstract]   [Full Text] [Related]  

  • 12. Myths and realities in medical packaging.
    Pilchik R
    Med Device Technol; 2003 Mar; 14(2):16-7. PubMed ID: 12698692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building comparative efficacy and tolerability into the FDA approval process.
    O'Connor AB
    JAMA; 2010 Mar; 303(10):979-80. PubMed ID: 20215612
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical devices and the approval processes: United States vs France.
    Braillon A
    Arch Intern Med; 2010 Dec; 170(22):2040-1. PubMed ID: 21149766
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical/surgical equipments. All eyes on safety.
    Haugh R
    Hosp Health Netw; 2001 Apr; 75(4):16, 18. PubMed ID: 11330128
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?
    Fargen KM; Frei D; Fiorella D; McDougall CG; Myers PM; Hirsch JA; Mocco J
    J Neurointerv Surg; 2013 Jul; 5(4):269-75. PubMed ID: 22764203
    [No Abstract]   [Full Text] [Related]  

  • 18. Missing evidence.
    Hayes WS
    MLO Med Lab Obs; 2008 Oct; 40(10):68. PubMed ID: 18988559
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA's response to the GAO's report: new effort to tighten the pre-market review process for select Class III medical devices.
    Kim JH; Smith J; Greis J; Werling K
    Health Care Law Mon; 2009 May; 2009(5):2-8. PubMed ID: 19449776
    [No Abstract]   [Full Text] [Related]  

  • 20. US manufacturing guideline for IVD products.
    Donawa M
    Med Device Technol; 2000 Oct; 11(8):23-4. PubMed ID: 11185183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.